Angioedema is a rare but potentially life-threatening adverse reaction to ACE inhibitors. Researchers have now conducted a genome-wide association study (GWAS) with more than 1,000 affected individuals. They identified a total of three risk loci in the genome. These included a new locus that had not previously been associated with the risk of ACE inhibitor-induced angioedema.